Affimed N.V. Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include Array BioPharma, Skyepharma and BTG.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |||
Founding Date | Founding Date 2000 | Founding Date 1998 | Founding Date 1996 | Founding Date 1948 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Heidelberg, DE HQ | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Saint-Quentin-Fallavier, FR HQ | |
Employees | Employees 76 | Employees 110 | Employees 2453% increase | Employees 650 |
Financial | ||||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods $59.4m (FY, 2018) | Cost of goods £43.1m (FY, 2015) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit $114.4m (FY, 2018) | Gross profit £52.8m (FY, 2015) | Gross profit £510.3m (FY, 2019) |
Net income | Net income (€105.9m) (FY, 2023) | Net income ($147.7m) (FY, 2018) | Net income N/A | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Array BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company
Skyepharma
HQ
Saint-Quentin-Fallavier, FR
Skyepharma is a drug delivery company developing oral and inhalation products.
View company